These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 15525796

  • 21. In vivo applications of PEG liposomes: unexpected observations.
    Laverman P, Boerman OC, Oyen WJG, Corstens FHM, Storm G.
    Crit Rev Ther Drug Carrier Syst; 2001; 18(6):551-66. PubMed ID: 11789675
    [Abstract] [Full Text] [Related]

  • 22. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
    Dams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, Corstens FH, Boerman OC.
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
    [Abstract] [Full Text] [Related]

  • 23. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S, Vali AM, Rezaie M.
    Int J Pharm; 2008 Apr 02; 353(1-2):251-9. PubMed ID: 18191511
    [Abstract] [Full Text] [Related]

  • 24. Particle size-dependent triggering of accelerated blood clearance phenomenon.
    Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N.
    Int J Pharm; 2008 Oct 01; 362(1-2):197-200. PubMed ID: 18586076
    [Abstract] [Full Text] [Related]

  • 25. Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.
    Lim HJ, Parr MJ, Masin D, McIntosh NL, Madden TD, Zhang G, Johnstone S, Bally MB.
    Clin Cancer Res; 2000 Nov 01; 6(11):4449-60. PubMed ID: 11106266
    [Abstract] [Full Text] [Related]

  • 26. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD, Huang L.
    Mol Pharm; 2006 Nov 01; 3(5):579-88. PubMed ID: 17009857
    [Abstract] [Full Text] [Related]

  • 27. Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
    Li WM, Mayer LD, Bally MB.
    J Pharmacol Exp Ther; 2002 Mar 01; 300(3):976-83. PubMed ID: 11861806
    [Abstract] [Full Text] [Related]

  • 28. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
    Metselaar JM, Bruin P, de Boer LW, de Vringer T, Snel C, Oussoren C, Wauben MH, Crommelin DJ, Storm G, Hennink WE.
    Bioconjug Chem; 2003 Mar 01; 14(6):1156-64. PubMed ID: 14624629
    [Abstract] [Full Text] [Related]

  • 29. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T, Wang X, Shimizu T, Nawata K, Kiwada H.
    J Control Release; 2007 Oct 08; 122(3):349-55. PubMed ID: 17610982
    [Abstract] [Full Text] [Related]

  • 30. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
    Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC, Karlsson G, Edwards K, Kenner G, Samuels L, Webb MS, Bally MB.
    Biochim Biophys Acta; 2007 Jun 08; 1768(6):1367-77. PubMed ID: 17400180
    [Abstract] [Full Text] [Related]

  • 31. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.
    Stuart DD, Kao GY, Allen TM.
    Cancer Gene Ther; 2000 Mar 08; 7(3):466-75. PubMed ID: 10766353
    [Abstract] [Full Text] [Related]

  • 32. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
    Shiraishi K, Hamano M, Ma H, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Yokoyama M.
    J Control Release; 2013 Feb 10; 165(3):183-90. PubMed ID: 23220106
    [Abstract] [Full Text] [Related]

  • 33. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H.
    J Control Release; 2009 Jul 01; 137(1):8-14. PubMed ID: 19285528
    [Abstract] [Full Text] [Related]

  • 34. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS, Uehara Y, Ishida T, Kiwada H.
    J Pharm Sci; 2014 Feb 01; 103(2):557-66. PubMed ID: 24347396
    [Abstract] [Full Text] [Related]

  • 35. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A.
    Park YS, Huang L.
    J Drug Target; 1993 Feb 01; 1(4):325-30. PubMed ID: 8069575
    [Abstract] [Full Text] [Related]

  • 36. Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes.
    Yamauchi M, Kusano H, Saito E, Iwata T, Nakakura M, Kato Y, Uochi T, Akinaga S, Aoki N.
    J Control Release; 2006 Aug 28; 114(2):268-75. PubMed ID: 16860428
    [Abstract] [Full Text] [Related]

  • 37. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA.
    Tagami T, Uehara Y, Moriyoshi N, Ishida T, Kiwada H.
    J Control Release; 2011 Apr 30; 151(2):149-54. PubMed ID: 21223988
    [Abstract] [Full Text] [Related]

  • 38. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production.
    Tagami T, Nakamura K, Shimizu T, Ishida T, Kiwada H.
    J Control Release; 2009 Aug 04; 137(3):234-40. PubMed ID: 19361546
    [Abstract] [Full Text] [Related]

  • 39. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A, Taniguchi Y, Kawano K, Honda T, Hattori Y, Maitani Y.
    Clin Cancer Res; 2008 Dec 15; 14(24):8161-8. PubMed ID: 19088031
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.